Hexanoic Acid Intake Enhances Anti‐Tumor Immune Responses in Colorectal Cancer by Reducing the Immunosuppressive Function of Tregs
Molecular Nutrition & Food Research · 2025
DOI: 10.1002/mnfr.70229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Daichi Seta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, T-Lymphocytes, Regulatory, Caproates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Mishima Kaiun Memorial Foundation, Nihon University.
Abstract (Originalsprache)
Colorectal cancer (CRC) remains a leading cause of cancer mortality worldwide. Regulatory T cells (Tregs) are key immune regulators that inhibit anti‐tumor immune responses by suppressing effector T‐cell functions and fostering an immunosuppressive tumor microenvironment. Despite epidemiological evidence showing an inverse association between milk consumption and CRC risk, the underlying mechanisms remain unclear. While milk‐derived fatty acids have demonstrated tumor‐suppressive activities, the anti‐tumor effects of hexanoic acid, a characteristic component of milk fat, have not been thoroughly investigated. Model tumor mice orally administered hexanoate, the sodium salt of hexanoic acid, showed increased hexanoic acid concentrations in tumor‐draining lymph nodes and tumor sites, with enhanced anti‐tumor immune responses that significantly suppressed cancer cell growth. These effects were mediated through the following: (1) suppressed differentiation of naïve CD4 + T cells into Tregs; (2) decreased Treg‐mediated inhibition of CD8 + T cells; and (3) suppressed intratumoral infiltration of Tregs, indirectly enhancing the effector function of CD8 + T cells. Furthermore, hexanoate enhanced the therapeutic effect of immune checkpoint inhibition therapy. Part of the protective effect of milk intake against CRC development may be mediated by hexanoic acid, which enhances anti‐tumor immune responses through its actions on Tregs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
- Department of Anatomy, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
- Department of Legal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan.
ORCID-Profile: Daichi Seta, Kenta Nagahori, Yuki Katoh
Förderung
- Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan
- Mishima Kaiun Memorial Foundation
- Nihon University
Zitieren
APA
Seta, D., Nagahori, K., Katoh, Y., Ogawa, T., Iwata, T., Nishio, H., Sugawara, M., Fujii, Y., Yoshido, A., Seno, H., & Hirai, S. (2025). Hexanoic Acid Intake Enhances Anti‐Tumor Immune Responses in Colorectal Cancer by Reducing the Immunosuppressive Function of Tregs. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70229
Vancouver
Seta D, Nagahori K, Katoh Y, Ogawa T, Iwata T, Nishio H, et al. Hexanoic Acid Intake Enhances Anti‐Tumor Immune Responses in Colorectal Cancer by Reducing the Immunosuppressive Function of Tregs. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70229
BibTeX
@article{Seta2025,
author = {Seta, Daichi and Nagahori, Kenta and Katoh, Yuki and Ogawa, Tadashi and Iwata, Takashi and Nishio, Hiroshi and Sugawara, Masaki and Fujii, Yosuke and Yoshido, Ayano and Seno, Hiroshi and Hirai, Shuichi},
title = {Hexanoic Acid Intake Enhances Anti‐Tumor Immune Responses in Colorectal Cancer by Reducing the Immunosuppressive Function of Tregs},
journal = {Molecular Nutrition & Food Research},
year = {2025},
doi = {10.1002/mnfr.70229}
}
EUVIMED